Healthcare and Life Sciences

The DarrowEverett Health Care & Life Sciences Practice advises clients across the heavily regulated and consistently evolving health care and life sciences industry. Service providers including hospitals; facilities; manufacturers; suppliers; lenders; investors; academia; and healthcare technology, biotechnology, food and dietary supplement, insurance, medical device, and pharmaceutical companies turn to us for assistance with the myriad of legal and regulatory issues and challenges that they face day to day in their businesses.

The DE team has extensive experience in healthcare mergers, acquisitions, joint ventures; strategic positioning, restructuring, capital access, private equity investments, divestitures, and bankruptcies. We aid with licensing, tax issues, government investigations, employment matters, governance, regulatory compliance, and Medicare/Medicaid reimbursement disputes and have litigated complex disputes involving commercial transactions and allegations of fraud, anti-kickback, and false claims act violations.

Our clients that manufacture or market products regulated by the US Food and Drug Administration (FDA) must also deal with the constantly changing procedural, regulatory, and legislative matters surrounding compliance, enforcement and product development, approvals, launch, sales, and marketing, reporting obligations, disclosures, and recalls.

The DE Health Care Practice Group regularly advises clients on:

  • Mergers, Acquisitions, & Sales
  • Financing, Restructuring, & Leasing
  • Medicare & Medicaid Reimbursement Disputes
  • Intellectual Property Issues
  • Licensure & Credentialing
  • Heath Insurance Portability & Accountability Act
  • Anti-kickback Laws
  • Corporate Integrity Agreements
  • Corporate, Regulatory, & Security Compliance
  • Employment, Contracting, & Negotiation
  • Stark Law
  • False Claims Act
  • Qui Tam Actions
  • FDA Registration
  • Health Information Technology
  • Litigation, Arbitration, & Administrative Hearings
  • Government Enforcement Actions
  • Federal & State Regulatory Compliance
  • Products Liability
  • Strategic Positioning
  • Senior & Elder Care Services
  • Clinical Investigations
  • Dispute Resolution
  • Labeling, Advertising, & Promotion
  • Product Recalls

Practice Leader

Kevin P. Gildea - Of Counsel


Kevin P. Gildea is a member of DarrowEverett’s Corporate & Business Transactions, Healthcare & Life Sciences, Regulatory & Compliance and Data Privacy & Cybersecurity Groups. He has a practice concentrated in the areas of corporate, banking, healthcare and life sciences, renewable energy, nonprofit, and financial services regulation, compliance, litigation and enforcement defense, and transaction and merger-acquisition related structuring, domestically and internationally. He has experience defending companies in civil and criminal government investigations and enforcement actions,...

Read more

Contact our Healthcare and Life Sciences Group.

Please contact us to let us know how DarrowEverett can serve you.

DE Insights

Our team wants you to stay informed about legal and regulatory developments that impact your business.

Fifth Circuit Puts the Brakes on SEC’s Private Fund Rules: What’s Next For Private Fund Advisers

In a continuation of recent court decisions overturning the rule-making authority of federal agencies, a recent decision by the U.S. Court of Appeals for the Fifth Circuit vacated the Securities and Exchange Commission’s (SEC) Private Fund Adviser Rules (the “Rules”), which had been adopted in August 2023. The Rules were aimed at increasing regulatory requirements…
Read more

Terminating Employees? Ignoring State And Local Wage Laws Can Cost You

Terminating employees can be a daunting task. Failing to follow your state or local rules when terminating an employee can make the task exponentially more difficult and expensive. When a business plans on firing or laying off an employee (known as “involuntary termination”) it is imperative business owners consult state and local laws prior to…
Read more

IRS Targeting Partnership Basis-Shifting Transaction Schemes

The Internal Revenue Service (“IRS,” or the “Service”) issued guidance on June 17, proposing new regulations and releasing a revenue ruling to challenge the use of basis-shifting transactions by complex partnerships. In making its announcement, IRS officials stated that closing this loophole could result in over $50 billion in new tax revenue for the U.S.…
Read more